Dr. Reddy's and Pharmazz, Inc. enter into licensing agreement to market first- in-class Centhaquine (Lyfaquin®) for hypovolemic shock in India
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.drreddys.com/cms/cms/sites/default/files/2024-03/Dr.%20Reddy's%20and%20Pharmazz,%20Inc.%20enter%20into%20licensing%20agreement%20to%20market%20first-in-class%20Centhaquine%20(Lyfaquin%C2%AE)%20for%20hypovolemic%20shock%20in%20India.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts:
